Michael Fiegl
- Molecular Biology top 5%
- Oncology top 1%
- Hematology top 0.5%
- Cancer Research top 1%
- Pulmonary and Respiratory Medicine top 2%
- Co-authors
- Michael AndreeffIsmael SamudioAlexandar TzankovWolfgang HilbeJohannes DrachWilliam SterlacciH. DenzHerbert Jamnig
- Topics
- Acute Myeloid Leukemia Research (30 papers)Lymphoma Diagnosis and Treatment (20 papers)Chronic Lymphocytic Leukemia Research (19 papers)
- Cited by
- HematologyCancer ResearchOncology
- Partner nations
- AustriaGermanySwitzerland
In The Last Decade
Michael Fiegl
163 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Molecular Biology 2.3k
- Oncology 1.9k
- Hematology 1.3k
- Cancer Research 1.1k
- Pulmonary and Respiratory Medicine 852
Countries citing papers authored by Michael Fiegl
This map shows the geographic impact of Michael Fiegl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Fiegl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Fiegl more than expected).
Fields of papers citing papers by Michael Fiegl
This network shows the impact of papers produced by Michael Fiegl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Fiegl. The network helps show where Michael Fiegl may publish in the future.
Co-authorship network of co-authors of Michael Fiegl
This figure shows the co-authorship network connecting the top 25 collaborators of Michael Fiegl. A scholar is included among the top collaborators of Michael Fiegl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Fiegl. Michael Fiegl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 5 | |
| 4 | Persistence of Driver Mutations during Complete Remission Associates with Shorter Survival and Contributes to the Inferior Outcomes of Elderly Patients with Acute Myeloid Leukemia | 2 |
| 5 | 10 | |
| 6 | 11 | |
| 7 | 6 | |
| 8 | 12 | |
| 9 | 26 | |
| 10 | 65 | |
| 11 | 7 | |
| 12 | 35 | |
| 13 | 22 | |
| 14 | 136 | |
| 15 | 11 | |
| 16 | 34 | |
| 17 | 7 | |
| 18 | 28 | |
| 19 | 28 | |
| 20 | 7 |
About Michael Fiegl
Michael Fiegl is a scholar working on Hematology, Genetics and Oncology, having authored 165 papers that have together received 5.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (30 papers), Lymphoma Diagnosis and Treatment (20 papers) and Chronic Lymphocytic Leukemia Research (19 papers). The work is most often cited by research in Hematology (1.3k citations), Cancer Research (1.1k citations) and Oncology (1.9k citations). Michael Fiegl has collaborated with scholars based in Austria, Germany and Switzerland. Frequent co-authors include Michael Andreeff, Ismael Samudio, Alexandar Tzankov, Wolfgang Hilbe, Johannes Drach, William Sterlacci, H. Denz, Herbert Jamnig, Niklas Zojer and Marina Konopleva. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.